High-yield soluble expression of recombinant influenza virus antigens from Escherichia coli and their potential uses in diagnosis

Yo Han Jang, Seung Hee Cho, Ahyun Son, Yun Ha Lee, Jinhee Lee, Kwang Hee Lee, Baik Lin Seong

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


Although antiviral drugs and vaccines have been successful for mitigating influenza virus infections, the lack of general technical platform for the timely supply of soluble and highly purified influenza viral antigens presents a serious bottleneck for the subsequent analysis for the effective control of the viral disease. Using the Escherichia coli (E. coli) lysyl tRNA synthetase (LysRS) as a novel fusion partner, this study reports the soluble expression of influenza viral proteins in E. coli host, construction of antibody library against the virus, and detection of anti-influenza antibodies using the expressed viral antigens. When influenza A and B viral proteins were fused with the LysRS, the fusion proteins were expressed predominantly as soluble forms and their production yields were high enough to be amenable to immunization protocols in rabbits for antibody generation. The produced antibodies showed high level binding specificity against the respective viral proteins, with cross-reactivity across heterologous viruses within the same type of influenza viruses. In addition, LysRS-HA fusion protein could bind specifically to anti-HA antibodies in the virus-infected mouse serum in widely accepted two detection methods, Western blot and ELISA. These results present a convenient tool for the production of antibodies specific to the virus as well as the rapid detection of influenza viral infections, ultimately contributing to the control of influenza viruses including highly pathogenic H5N1, pandemic H1N1, or the recent H7N9 influenza viruses.

Original languageEnglish
Pages (from-to)56-64
Number of pages9
JournalJournal of Virological Methods
Publication statusPublished - 2014 Feb

Bibliographical note

Funding Information:
This work was supported by a grant from the Korea Healthcare Technology R&D project of Ministry for Health , Welfare and Family Affairs of Republic of Korea [Grant number A085105 ]. The funding source did not have roles in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.

All Science Journal Classification (ASJC) codes

  • Virology


Dive into the research topics of 'High-yield soluble expression of recombinant influenza virus antigens from Escherichia coli and their potential uses in diagnosis'. Together they form a unique fingerprint.

Cite this